Programme Day 2

• Universal CKD Screening - To Do or Not to Do?

• Hemoadsorption in Maintenance Hemodialysis: Mechanistic Rationale and Clinical Integration

• All Elderly Patients With ESKD Should Be Offered Non-Dialysis Care

• Sponsored by GSK

• Permissive AKI : Friend or Foe?
• AKI in Pregnancy
• Sepsis-Associated AKI - Is Blood Purification Finally Evidence-Based Driven?
• Q&A

• How to Handle Tenckhoff Catheter Malfunction
• Common Pitfalls in HD Catheter Insertion
• US Guided AVF Cannulation
• Q&A

• Moving Towards to Cystatin-C Based eGFR
• Treating Osteoporosis in CKD
• “Is Gym and Extreme Exercise Bad for Your Kidney?”
• Q&A

• Sponsored by AstraZeneca

• Sponsored by DKSH

• Sponsored by Novo Nordisk

• Operationalising Genetic Testing in Nephrology: Practical Lessons from Thailand
• Fabry Disease in Asia: Insights from Taiwan’s Experience with Screening & Enzyme Therapy
• Alport Syndrome: Molecular Pathogenesis, Diagnostic Frontier and Clinical Management- Singaporean Experience
• Q&A

• BP Management in Dialysis Population
• Science vs Art in PD Prescription
• Preventing and treating frailty in dialysis patients
• Q&A

• How to Handle Resistant Hypertension?
• Renal Artery Stenosis
• Aldosterone Synthase Inhibitor - Promising New Agent
• Q&A

• Sponsored by GSK